<DOC>
<DOCNO>EP-0614899</DOCNO> 
<TEXT>
<INVENTION-TITLE>
5-Phenyl-pyrrolo-1,4-benzoxazine and thiazine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K31535	A61K31535	A61K315375	A61K31538	A61K3154	A61K3154	A61K315415	A61K315415	A61P2900	A61P2900	A61P3700	A61P3708	C07D26500	C07D26536	C07D27900	C07D27916	C07D49800	C07D49806	C07D51300	C07D51306	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61P	A61P	A61P	A61P	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61P29	A61P29	A61P37	A61P37	C07D265	C07D265	C07D279	C07D279	C07D498	C07D498	C07D513	C07D513	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Pharmacologically active compounds of the general formula I 
<
IMAGE
>
  which can be substituted in the phenyl rings and  in which     R
<
1
>
 is hydrogen or lower alkyl,   R
<
6
>
 is hydrogen or lower alkyl,   Y is oxygen or sulphur,   n is a number from 1 to 3,   Z is a bond, the CO group or the CH2 group,   Q is nitrogen or the CH group and R
<
7
>
, if Q is nitrogen, is an optionally substituted pyridyl or phenyl radical, or, if Q is the CH group, is the N-methyl-N-(4-oxo-3H-pyrimidin-2-yl)amino group, and their acid addition salts and process and intermediates for their preparation are described.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
KALI CHEMIE PHARMA GMBH
</APPLICANT-NAME>
<APPLICANT-NAME>
KALI-CHEMIE PHARMA GMBH
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
DEMONCHAUX PATRICE
</INVENTOR-NAME>
<INVENTOR-NAME>
LENOIR PATRICK
</INVENTOR-NAME>
<INVENTOR-NAME>
DEMONCHAUX, PATRICE
</INVENTOR-NAME>
<INVENTOR-NAME>
LENOIR, PATRICK
</INVENTOR-NAME>
</INVENTORS>
</TEXT>
</DOC>
